Matthias Gromeier, MD Duke University Medical School

Dr. Gromeier is Professor of Neurosurgery and the Preston Robert Tisch Brain Tumor Center at Duke University Medical School. He is pioneering brain tumor immunotherapy with recombinant poliovirus (PVSRIPO). This approach has shown promise in patients with recurrent glioblastoma, producing long-term tumor control/survival with high quality of life. FDA/CBER granted Breakthrough Therapy Designation to PVSRIPO in 2016.